MEDICO · Healthcare · Drug Manufacturers - Specialty & Generic
Composite scorecard: 42/100 — Quality 38 · Valuation 58 · Momentum 28
| Share price | ₹38.23 |
| Market cap | ₹330 Cr |
| P/E ratio | 25.1 |
| P/B ratio | 4.3 |
| ROE | 79.0% |
| ROCE | 26.2% |
| Book value | ₹9.15 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹206 Cr | ₹13 Cr | 6.8% |
| 2025 | ₹151 Cr | ₹10 Cr | 7.9% |
| 2024 | ₹143 Cr | ₹8 Cr | 7.0% |
| 2023 | ₹138 Cr | ₹7 Cr | 5.0% |
| 2022 | — | — | — |
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It also exports its products.